Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.81% | 1.71% | 2.33% | 9.77% | 4.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.81% | 1.71% | 2.33% | 9.77% | 4.56% |
| Cost of Revenue | -11.89% | -23.07% | -10.92% | 1.04% | -11.80% |
| Gross Profit | -15.89% | 11.85% | 7.64% | 13.44% | 12.19% |
| SG&A Expenses | 0.81% | -8.53% | -9.55% | -50.65% | -51.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.19% | -18.77% | -11.63% | -35.04% | -41.80% |
| Operating Income | -30.38% | 73.90% | 58.19% | 89.65% | 88.09% |
| Income Before Tax | -36.39% | 80.62% | 53.44% | 91.22% | 89.20% |
| Income Tax Expenses | 8.77% | -83.27% | 5.34% | 28.63% | 22.71% |
| Earnings from Continuing Operations | -35.93% | 80.79% | 53.11% | 91.01% | 89.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.93% | 80.79% | 53.11% | 91.01% | 89.04% |
| EBIT | -30.38% | 73.90% | 58.19% | 89.65% | 88.09% |
| EBITDA | -505.27% | 80.18% | 42.63% | 101.73% | 97.52% |
| EPS Basic | -39.01% | 81.05% | 55.08% | 91.43% | 89.55% |
| Normalized Basic EPS | -39.53% | 64.44% | 55.39% | -- | 89.71% |
| EPS Diluted | -39.01% | 81.05% | 55.08% | 91.43% | 89.55% |
| Normalized Diluted EPS | -39.53% | 64.44% | 55.39% | -- | 89.71% |
| Average Basic Shares Outstanding | -2.25% | 1.36% | 4.37% | 4.96% | 4.95% |
| Average Diluted Shares Outstanding | -2.25% | 1.35% | 4.38% | 4.96% | 4.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |